Premium
The treatment of a thyrotropin‐secreting pituitary macroadenoma with octreotide in twin pregnancy
Author(s) -
Blackhurst G.,
Strachan M. W.,
Collie D.,
Gregor A.,
Statham P. F. X.,
Seckl J. E. R.
Publication year - 2002
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1046/j.1365-2265.2002.01549.x
Subject(s) - octreotide , medicine , pregnancy , euthyroid , endocrinology , refractory (planetary science) , adenoma , pituitary adenoma , pituitary tumors , pituitary gland , hormone , somatostatin , biology , genetics , astrobiology
Summary TSH‐secreting pituitary tumours are rare but difficult to treat due to a combination of refractory hyperthyroidism and low surgical cure rates. We describe the case of a 21‐year‐old woman who, despite twin pregnancy, became euthyroid and had dramatic tumour shrinkage on octreotide treatment. To our knowledge, this is the first description of the use of octreotide for a TSH‐secreting pituitary adenoma throughout pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom